Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 15, 2026

C-arm-Free Simultaneous OLIF51 and Percutaneous Pedicle Screw Fixation in a Single Lateral Position
12:25

C-arm-Free Simultaneous OLIF51 and Percutaneous Pedicle Screw Fixation in a Single Lateral Position

Published on: September 16, 2022

Consecutive field trials using two different intraosseous devices.

Ralph J Frascone1, Joe P Jensen, Kory Kaye

  • 1Regions Hospital Emergency Medical Services, Regions Hospital, St. Paul, MN 55101, USA.

Prehospital Emergency Care
|April 25, 2007
PubMed
Summary

The EZ-IO device demonstrated a higher success rate for intraosseous (IO) access compared to the F.A.S.T.1 system in prehospital settings. Further randomized trials are needed to confirm these findings on IO device performance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of prehospital TXA on mortality and neurologic outcomes in patients with traumatic intracranial hemorrhage: A subgroup analysis from the prehospital TXA for TBI trial.

The journal of trauma and acute care surgery·2024
Same author

Rationale and Strategies for Development of an Optimal Bundle of Management for Cardiac Arrest.

Critical care explorations·2020
Same author

Elimination of Routine Screening Laboratory Tests for Psychiatric Admission: A Quality Improvement Initiative.

Psychiatric services (Washington, D.C.)·2020
Same author

Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.

The journal of trauma and acute care surgery·2020
Same author

Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.

JAMA·2020
Same author

Supraglottic airway devices variably develop negative intrathoracic pressures: A prospective cross-over study of cardiopulmonary resuscitation in human cadavers.

Resuscitation·2020

Area of Science:

  • Emergency Medicine
  • Trauma Care
  • Medical Device Evaluation

Background:

  • Establishing intravenous (IV) access can be challenging in adult trauma and medical patients.
  • Intraosseous (IO) access offers an alternative route for fluid and medication delivery when IV access is difficult.
  • Two FDA-approved IO devices, F.A.S.T.1 and EZ-IO, are available for prehospital use.

Purpose of the Study:

  • To compare the performance of the F.A.S.T.1 and EZ-IO intraosseous devices in prehospital settings.
  • To evaluate provider success rates, comfort, and satisfaction with each IO device.
  • To identify potential differences in device efficacy and ease of use by emergency medical providers.

Main Methods:

  • Two sequential field trials were conducted involving prehospital providers.

More Related Videos

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage
11:51

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage

Published on: February 10, 2014

Related Experiment Videos

Last Updated: Jul 15, 2026

C-arm-Free Simultaneous OLIF51 and Percutaneous Pedicle Screw Fixation in a Single Lateral Position
12:25

C-arm-Free Simultaneous OLIF51 and Percutaneous Pedicle Screw Fixation in a Single Lateral Position

Published on: September 16, 2022

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage
11:51

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage

Published on: February 10, 2014

  • Trial 1 evaluated the F.A.S.T.1 system with 124 participating providers.
  • Trial 2 evaluated the EZ-IO system with 389 participating providers, collecting data on insertion success, comfort, and satisfaction.
  • Main Results:

    • The EZ-IO achieved a significantly higher success rate (87%) compared to the F.A.S.T.1 (72%) (p = 0.009).
    • Providers using the EZ-IO attempted fewer prior IV insertions (2.0) than those using F.A.S.T.1 (2.6) (p = 0.005).
    • No significant differences were found in provider comfort or assessed device performance between the two devices.

    Conclusions:

    • The EZ-IO device demonstrated superior insertion success rates compared to the F.A.S.T.1 in this prehospital study.
    • Limitations include non-randomization, sequential trial design, potential learning effects, and self-reported data.
    • A prospective, randomized evaluation is recommended to definitively assess provider insertion success rates for these IO devices.